↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

78 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   5-methyl-1-phenyl-2-1-(h)-pyridone   -   -   -   -   1件:
228 
 2   Aerolised liposomal ciclosporin a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 3   Azithromycin   Azithromycin   D02134, D06390, D07486   -   -   6件:
13,
84,
85,
96,
228,
299 
 4   Azithromycin (zitromax°)   Azithromycin   D02134, D06390, D07486   -   -   1件:
228 
 5   Azithromycin + n-acetylcystein + inhaled corticosteroid   Azithromycin   D02134, D06390, D07486   -   -   1件:
228 
 6   Azithromycin dihydrate   Azithromycin   D02134, D06390, D07486   -   -   2件:
228,
299 
 7   Azithromycine   Azithromycin   D02134, D06390, D07486   -   -   1件:
228 
 8   Azithromycine 250 mg   Azithromycin   D02134, D06390, D07486   -   -   1件:
228 
 9   Aztreonam   Aztreonam   D00240, D06558   -   -   2件:
228,
299 
 10   Aztreonam lysine for inhalation (azli)   Aztreonam, L-Lysine   D00240, D02304, D06558   -   -   1件:
228 
 11   Basiliximab   Basiliximab   D03058   1件: IL2RA   4件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, JAK-STAT signaling pathway   6件:
2,
50,
65,
97,
222,
228 
 12   Bortezomib   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 13   Budesonide   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   9件:
66,
93,
94,
95,
96,
97,
98,
228,
299 
 14   Budesonide/formoterol   Budesonide, Formoterol   D00246, D01373, D05277, D07990   2件: ADRB2, NR3C1   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
228 
 15   Certican   Everolimus   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   2件:
96,
228 
 16   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 17   Ciclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   13件:
26,
46,
49,
50,
53,
55,
60,
61,
97,
222,
226,
228,
269 
 18   Ciclosporin (ciclosporinium)   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 19   Ciclosporin a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 20   Ciclosporina   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
49,
228 
 21   Ciclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
60,
228 
 22   Ciclosporine, ciclosporina   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 23   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 24   Colecalciferol   Cholecalciferol   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   4件:
13,
46,
96,
228 
 25   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 26   Cyclosporine a dry powder inhalation (drug)   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 27   Cyclosporine inhalation solution   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 28   Cyclosporine inhalation solution (cis)   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 29   D-cure   -   -   -   -   1件:
228 
 30   Erythromycin   Erythromycin   D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054   -   -   5件:
6,
36,
164,
228,
291 
 31   Esbriet   Pirfenidone   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   3件:
51,
85,
228 
 32   Etanercept   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   14件:
15,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298 
 33   Fam therapy   -   -   -   -   1件:
228 
 34   Fluticasone   Fluticasone propionate   D01708   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   4件:
98,
228,
299,
306 
 35   Fluticasone propionate   Fluticasone propionate   D01708   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
98,
228,
306 
 36   Formoterol   Formoterol   D01373, D05277, D07990   1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
228,
299,
306 
 37   Formoterol/budesonide   Budesonide, Formoterol   D00246, D01373, D05277, D07990   2件: ADRB2, NR3C1   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
228 
 38   Glucocorticoid   -   -   -   -   2件:
46,
228 
 39   Helium   Helium   D04420   -   -   3件:
228,
299,
330 
 40   Helium-3   Helium, Helium He-3   D04420   -   -   2件:
228,
299 
 41   Hp 129xenon   -   -   -   -   1件:
228 
 42   Hyperpolarized helium-3 mri   Helium, Helium He-3   D04420   -   -   1件:
228 
 43   Imukin   -   -   -   -   1件:
228 
 44   Inhalation   -   -   -   -   1件:
228 
 45   Interferon gamma-1b   Interferon gamma-1b   D00747   2件: IFNGR1, IFNGR2   4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Pathways in cancer   7件:
65,
85,
90,
228,
299,
301,
326 
 46   Itacitinib   Itacitinib   D10944   1件: JAK1   2件: JAK-STAT signaling pathway, PI3K-Akt signaling pathway   4件:
46,
60,
97,
228 
 47   L-csa   -   -   -   -   1件:
228 
 48   Lactose   Lactose   D00046, D03226   -   -   6件:
2,
6,
13,
97,
228,
310 
 49   Liposomal aerosol cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 50   Liposomal cyclosporine a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
228 
 51   Lysine   L-Lysine   D02304   -   -   4件:
13,
97,
228,
299 
 52   Mesenchymal stem cell 0.5   -   -   -   -   1件:
228 
 53   Mesenchymal stem cell 1.0   -   -   -   -   1件:
228 
 54   Montelukast   Montelukast   D00529, D08229   1件: CYSLTR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   5件:
13,
46,
85,
98,
228 
 55   Montelukast sodium   Montelukast   D00529, D08229   1件: CYSLTR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   1件:
228 
 56   Montelukast teva   Montelukast   D00529, D08229   1件: CYSLTR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   1件:
228 
 57   Mph966   -   -   -   -   1件:
228 
 58   Mscs   -   -   -   -   1件:
228 
 59   Myfortic   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   4件:
49,
66,
222,
228 
 60   Nintedanib   Nintedanib   D10481   8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB   3件: MAPK signaling pathway, Pathways in cancer, VEGF signaling pathway   4件:
51,
85,
89,
228 
 61   Ofev   Nintedanib   D10481   8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB   3件: MAPK signaling pathway, Pathways in cancer, VEGF signaling pathway   4件:
51,
85,
89,
228 
 62   Other sources   -   -   -   -   1件:
228 
 63   Pirfenidone   Pirfenidone   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   10件:
34,
46,
50,
51,
58,
84,
85,
164,
222,
228 
 64   Pirfenidone 267 mg [esbriet]   Pirfenidone   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   1件:
228 
 65   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 66   Ruxolitinib   Ruxolitinib   D09959   2件: JAK1, JAK2   3件: Chemokine signaling pathway, JAK-STAT signaling pathway, Pathways in cancer   1件:
228 
 67   Salbutamol   Salbutamol   D02147   1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   8件:
3,
11,
49,
85,
86,
228,
256,
299 
 68   Singulair   Montelukast   D00529, D08229   1件: CYSLTR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   1件:
228 
 69   Singulair (montelukast sodium)   Montelukast   D00529, D08229   1件: CYSLTR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   1件:
228 
 70   Sodium chloride   Chloride ion, Sodium chloride   D02056   -   -   13件:
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 71   Sodium chloride solution   Chloride ion, Sodium chloride   D02056   -   -   3件:
11,
13,
228 
 72   Sodium chloride solvent   Chloride ion, Sodium chloride   D02056   -   -   1件:
228 
 73   Symbicort   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
85,
228 
 74   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 75   Vitamin d   Vitamin D   -   -   -   18件:
13,
19,
41,
46,
49,
50,
68,
93,
95,
96,
98,
179,
222,
228,
235,
274,
298,
299 
 76   Xenon   Xenon-133   -   -   -   5件:
22,
85,
228,
231,
299 
 77   Zithromax   Azithromycin   D02134, D06390, D07486   -   -   2件:
228,
299 
 78   Zitromax   zitromax   D02134, D06390, D07486   -   -   2件:
228,
299 

先頭へ